SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is surging after exceeding earnings expectations, fueled by an 84% jump in cloud infrastructure revenue and a substantial increase in remaining performance obligations that signal robust AI-driven demand, reassuring investors about its growth trajectory and capacity funding. The community is actively discussing Oracle's transformation into a key AI infrastructure provider, anticipating further price action and a potential short squeeze.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp is trending as it prepares for its uplisting to the NYSE, with its CEO gaining significant media exposure discussing the company's strategic importance. This comes amid community excitement over a recent Department of War award to expand antimony production and a major tungsten resource discovery, reinforcing its critical role in national defense and technology.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as recent in-line CPI data is met with skepticism amidst escalating Middle East tensions and concerns over global oil supply, fueling community debate on market stability and future inflation.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending amid heightened volatility, driven by conflicting reports surrounding the Iran conflict's impact on oil, alongside in-line CPI data and strong Oracle earnings that are providing a lift to the tech-heavy index; however, the community widely debates market manipulation and the sustainability of recent rallies.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Round Rock, TX.

TSS Inc

TSS Inc. is surging following exceptional Q4 earnings that significantly beat expectations, driven by strong AI rack integration demand and an extended multi-year agreement with its largest customer. The community is actively discussing the potential for a massive short squeeze as the company projects doubling its AI integration volumes amid the broader data center buildout.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending as it rapidly expands its autonomous mobility ecosystem, driven by new robotaxi partnerships with Amazon's Zoox and Wayve, the launch of Uber Air with Joby, and the strategic acquisition of parking app SpotHero. The community sees these moves, alongside investments in EV charging infrastructure, as key to solidifying its future market dominance despite ongoing market fluctuations.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is a hot topic following a significant $2 billion strategic investment from NVIDIA and the approval of a massive gigawatt-scale AI factory in Independence, Missouri, with the community noting that customer upfront payments further underscore its robust position and growth potential in the AI infrastructure sector.

CitroTech, Inc. is an integrated environmental service company, which engages in the provision of field services, remediation transportation, and EHS compliance services. It also offers on-site technical services, on-site and off-site treatment for hazardous and non-hazardous waste. The company was founded on March 14, 1990 and is headquartered in Cheyenne, WY.

CitroTech Inc.

CitroTech Inc. is trending as its unique EPA Safer Choice certified fire prevention technology and initial commercial lumber rollout gain significant institutional and retail investor attention following a recent conference. The company's tight share float and strong narrative around escalating wildfire prevention needs are driving discussions of potential re-rating and further momentum.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending with high anticipation for its upcoming earnings report, as its recent AIUC-1 certification highlights its role in secure enterprise AI agent orchestration, driving polarized community discussion and short-squeeze speculation.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is seeing intense volatility as investors balance a flight to safety against rising oil prices and a hotter-than-expected PPI report, fueling community debate on whether persistent inflation or geopolitical de-escalation will dictate the path for long-term Treasury yields and future rate cuts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Royalty Pharma PLC $RPRX is Regal Partners Ltd's 10th Largest Position

Regal Partners Ltd raised its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 6.7% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The...

Neo Ivy Capital Management Buys New Position in Royalty Pharma PLC $RPRX

Neo Ivy Capital Management purchased a new position in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the...

Goodman Advisory Group LLC Purchases New Stake in Royalty Pharma PLC $RPRX

Goodman Advisory Group LLC purchased a new stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the third quarter, according to the company in its most recent 13F filing with the SEC...

CM Management LLC Takes $1.76 Million Position in Royalty Pharma PLC $RPRX

CM Management LLC purchased a new position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange...

Royalty Pharma (NASDAQ:RPRX) Reaches New 12-Month High - Still a Buy?

Royalty Pharma (NASDAQ:RPRX) Reaches New 12-Month High - Time to Buy...

Royalty Pharma (NASDAQ:RPRX) CFO Terrance Coyne Sells 34,791 Shares

Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) CFO Terrance Coyne sold 34,791 shares of Royalty Pharma stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of...

Victory Capital Management Inc. Purchases 165,727 Shares of Royalty Pharma PLC $RPRX

Victory Capital Management Inc. raised its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 3.7% during the third quarter, according to its most recent disclosure with the...

TD Asset Management Inc Acquires 91,136 Shares of Royalty Pharma PLC $RPRX

TD Asset Management Inc raised its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 88.4% in the third quarter, according to its most recent 13F filing with the Securities & Exchange...

Quantbot Technologies LP Makes New $2.82 Million Investment in Royalty Pharma PLC $RPRX

Quantbot Technologies LP bought a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange...

Mitsubishi UFJ Asset Management Co. Ltd. Buys 44,289 Shares of Royalty Pharma PLC $RPRX

Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 14.2% in the third quarter, according to its most recent Form 13F filing with the...

Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

Current Price	$45.97
Prev Close	$45.84
Open	$45.91
Dividend Yield	2.28%
50-Day Moving Average	$42.69
Beta	0.32
Avg. Volume	3.82M
PE Ratio	25.82

52-Week High	$47.86
52-Week Low	$29.66
Market Capitalization	$26.52B
EPS (Annual)	$1.78
Price to Book	3.04
Revenue Per Employee	$23.78M

RPRX
Royalty Pharma plc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RPRX News

RPRXRoyalty Pharma plc - Ordinary Shares - Class A